艾吉纳斯 AGEN 深 沪
等待开盘 07-29 09:30:00 美东时间
6.35
+0.390
+6.54%
华盛通- 最 高6.58
- 今 开6.00
- 成交量 122.78万股
- 最 低 5.90
- 昨 收 5.96
- 总市值 1.74亿
- 52周最高 7.34
- 市盈率 静 --
- 换手率 4.48%
- 52周最低 1.38
- 委 比 -19.71%
- 总股本 2741.69万
- 历史最高 202.5868
- 量 比 1.54
- 振 幅 11.41%
- 历史最低 1.38
- 每 手 1
- 风险率 1.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Agenus To Present Clinical Progress Across Botensilimab And Balstilimab Immunotherapy Programs At ESMO Congress 2025
Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology, today announced that four abstracts highlighting clinical progress across its botensilimab and balstilimab immunotherapy programs have been accepted for
07-26 00:55
招商研究 | 招闻天下0724
（来源：招商研究） 本资料由招商证券研究发展中心汇编而成，仅供客户中的专业投资者参考。具体投资观点请以研究报告的完整内容为准，投研活动信息等请联系对口销售。为保...
07-24 07:30
GLOBE LIFE INC. REPORTS SECOND QUARTER 2025 RESULTS
MCKINNEY, Texas, July 23, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2025, net income was $3.05 per diluted common share, compared wit...
07-24 04:10
迈富时(2556.HK)首次覆盖报告：AI AGENT重构营销SAAS范式 迈富时如何突破50%营收增长边界？
公司介绍：迈富时业务由AI SaaS+精准营销双轮驱动，SaaS 产品主要包括面向大型客户的T 云和面向中小型企业的珍客，商业模式以订阅制为主，AIAgent...
07-22 07:27
美股牛股 | MiNK Therapeutics, Inc.涨超730%，癌症治疗取得突破
MiNK Therapeutics, Inc.涨730.1%；Above Food Ingredients Inc. Ordinary Shares涨134.2%；新蛋涨71.4%
07-12 09:24
Agenus unit, MiNK surges after peer-reviewed data for lead drug
Shares of MiNK Therapeutics (NASDAQ:INKT) climbed over 500% in the morning hours on Friday after the nano-cap cell therapy developer, which is a unit of Agenus (NASDAQ:AGEN), announced peer-reviewed d...
07-11 23:12
Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate
Adagene has partnered with ConjugateBio to provide a proprietary antibody for the development of novel bispecific ADCs. Adagene will receive upfront, milestone, and royalty payments, while retaining non-ADC rights to the antibody. The partnership leverages Adagene’s antibody discovery capabilities and ConjugateBio’s ADC development expertise, targeting solid tumors with innovative therapeutics.
07-08 11:00
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Mustang Bio (NASDAQ:MBIO) stock increased by 217.6% to $3.78 during Mo...
07-08 01:06
Agenus Confirms Agreement With FDA On Design Of Global BATTMAN Phase 3 Trial
Agenus also confirmed that it has reached agreement with the U.S. Food and Drug Administration (FDA) on the design of the global BATTMAN Phase 3 trial. The FDA waived the need for a BOT monotherapy arm, allowing for a
07-07 20:59
Agenus Announces Research Collaboration To Develop Predictive Biomarkers Of Response To Clinical Stage IO Combination, Botensilimab
Partnership aims to accelerate precision immunotherapy by leveraging AI-powered virtual cell models to identify which patients are most likely to benefit from BOT/BAL treatmentCollaboration builds on landmark 2024 Cancer
06-17 19:31
